TP53 mutations are the most common genetic alterations in HNSCC (50–80%), mostly in exons 5 to 8 which encode the DNA binding domain of the protein (L1-L2 region) [15,162,163]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.